Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Obsessive-Compulsive Disorder: Formal and Content Modalities, Factors Involved in Loss of Insight, Role of Trauma, and Correlations With Schizophrenia Spectrum Disorders

NCT07092826 is registered in ClinicalTrials.gov with Matteo Tonna as lead sponsor.

NCT NCT07092826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07092826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Obsessive-Compulsive Disorder: Formal and Content Modalities, Factors Involved in Loss of Insight, Role of Trauma, and Correlations With Schizophrenia Spectrum Disorders
Lead sponsor
Matteo Tonna
Phase
Observational
Overall status
Active, not recruiting
Start date
February 1, 2023
Completion date
February 1, 2026
Enrollment
300 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

obsessive-compulsive disorder (ocd), schizophrenia and schizophrenia spectrum psychosis